BPA Call HT941024A0007-HT941026FE031
Award Date 3/11/26
Potential Completion Date 3/31/26
Potential Value $44K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. for chemistry and immunoassay testing system reagents and supplies, with a ceiling value of $35,907.65 and an award date of March 10, 2026. The call was issued under a $2.875 million single-award BPA with the Defense Health Agency (effective July 1, 2024 through June 30, 2029) for VITROS 7600 laboratory testing equipment consumables. Performance occurs in Japan and is scheduled for completion by March 31, 2026. The...
- The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on February 2, 2026, for VITROS reagent and supplies, with a ceiling value of $45,974.02 and completion date of February 15, 2026. The call is issued under a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $250,000, awarded October 1, 2025, through September 30, 2030, for laboratory medical supplies supporting the Medical Department Activity in Japan. Performance occurs in Japan. The...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $50,053.35 to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider Ortho Clinical Diagnostics, for VITROS Chemistry and Immunoassay Analyzer testing reagents and consumables. The contract, awarded on November 5, 2025, with an ultimate completion date of November 17, 2025, operates under a firm fixed-price structure with no socioeconomic set-aside designation....
- The Defense Health Agency awarded a $17,255.88 blanket purchase agreement (BPA) call to Ortho Clinical Diagnostics K.K. for VITROS chemistry and immunoassay analyzer testing reagents and consumables. This firm fixed-price contract, awarded on January 28, 2026, with a completion date of February 13, 2026, supports clinical laboratory diagnostic operations at U.S. military medical facilities throughout Japan. The award carries no socioeconomic set-aside designation and represents a delivery...
- The Defense Health Agency awarded a $26.5K firm fixed-price blanket purchase agreement (BPA) call to Ortho Clinical Diagnostics K.K. on January 5, 2026, for VITROS chemistry and immunoassay analyzer testing reagents and consumables, with completion targeted for January 30, 2026. The award carries no socioeconomic set-aside designation and will be performed in Japan. Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider Ortho Clinical...
- The Defense Health Agency awarded a $17,926.76 firm fixed-price BPA call to Ortho Clinical Diagnostics K.K. on February 24, 2025, with an ultimate completion date of March 3, 2025. The contract covers Chemistry and Immunoassay Testing System (VITROS and VITROS 7600) reagents and consumable supplies to be delivered to Japan. This award was not made under a socioeconomic set-aside program and represents a delivery order against the vendor's existing blanket purchase agreement with the Defense...
- The Defense Health Agency awarded a $11,472.90 firm fixed-price blanket purchase agreement call to Ortho Clinical Diagnostics K.K. for VITROS chemistry and immunoassay analyzer testing reagents and consumables. The contract was awarded on December 15, 2025, with an ultimate completion date of December 19, 2025, and will be performed in Japan. This award carries no socioeconomic set-aside designation and represents a delivery order issued under one of the contractor's existing indefinite-delivery...
- The Defense Health Agency awarded a $30,041.39 firm fixed-price Blanket Purchase Agreement (BPA) call to Ortho Clinical Diagnostics K.K. on July 25, 2025, for chemistry and immunoassay testing system reagents and supplies, with a completion date of September 30, 2025. The work will be performed in Japan and supports critical laboratory diagnostic operations at U.S. military medical facilities throughout the Indo-Pacific region. This call order is issued under the vendor's existing $2.875 million...
- The Defense Health Agency awarded a $17,926.71 firm fixed-price Blanket Purchase Agreement (BPA) call to Ortho Clinical Diagnostics K.K. on July 23, 2025, for chemistry and immunoassay testing system reagents and supplies. The contract, which carries no socioeconomic set-aside designation, is scheduled for completion by September 30, 2025, and will be performed in Japan. Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider Ortho Clinical...
- The Defense Health Agency awarded a $19,443.19 firm fixed-price Blanket Purchase Agreement call to Ortho Clinical Diagnostics K.K. on September 4, 2025, for chemistry and immunoassay testing system reagents and supplies. The work will be performed in Japan with an ultimate completion date of September 15, 2025. This call is issued under a larger $2.875M single-award BPA established July 1, 2024, through June 30, 2029, for VITROS 7600 laboratory testing equipment consumables supporting U.S....